Anti-CD40L therapy prevents the formation of precursor lesions to gastric B-cell MALT lymphoma in a mouse model. Ying L, Liu P, Ding Z, Wray-McCann G, et al. J Pathol 2023;259:402-414.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ying L, Liu P, Ding Z, Wray-McCann G, et al. Anti-CD40L therapy prevents the formation of precursor lesions to gastric B-cell MALT lymphoma in a mouse model. J Pathol 2023;259:402-414.
PMID: 36640261